Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
Recruiting
Early Phase 1
Interventional Study
Idiopathic Pulmonary Fibrosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 6 (estimated)
- Sponsor
- University of Virginia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Idiopathic pulmonary fibrosis has a poor prognosis with limited treatment options. The Investigator hypothesize hyperpolarized Xe129-MRI can be performed in patients with IPF and repeated over time which will detect deficiencies related to perfusion in the lung.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Able to provide informed consent 18 years of age or greater Clinical diagnosis of IPF
Exclusion Criteria:
* Continuous oxygen use at home
* Oxygen saturation less than 92% on the day of MRI procedure
* Pregnancy or lactation
* Claustrophobia, inner ear implants, aneurysm or …